Chitosan-based nanoformulated (–)-epigallocatechin-3-gallate (EGCG) modulates human keratinocyte-induced responses and alleviates imiquimod-induced murine psoriasiform dermatitis

Chitosan-based nanoformulated (–)-epigallocatechin-3-gallate (EGCG) modulates human keratinocyte-induced responses and alleviates imiquimod-induced murine psoriasiform dermatitis

Jean Christopher Chamcheu,1,2,* Imtiaz A Siddiqui,1,* Vaqar M Adhami,1,* Stephane Esnault,3 Dhruba J Bharali,4 Abiola S Babatunde,1,5 Stephanie Adame,1 Randall J Massey,6 Gary S Wood,1 B Jack Longley,1 Shaker A Mousa,4 Hasan Mukhtar11Department of Dermatology, School of Medicine and Public...

Full description

Bibliographic Details
Main Authors: Chamcheu JC, Siddiqui IA, Adhami VM, Esnault S, Bharali DJ, Babatunde AS, Adame S, Massey RJ, Wood GS, Longley BJ, Mousa SA, Mukhtar H
Format: Article
Language:English
Published: Dove Medical Press 2018-07-01
Series:International Journal of Nanomedicine
Subjects:
Chitosan nanoparticles
topical delivery of chitosan nanoformulated EGCG
psoriasis-like skin inflammation
phytochemical treatment of psoriasis
normal human epidermal keratinocytes
differentiation
anti-inflammatory action.
Online Access:https://www.dovepress.com/chitosan-based-nanoformulated-epigallocatechin-3-gallate-egcg-modulate-peer-reviewed-article-IJN

Internet

https://www.dovepress.com/chitosan-based-nanoformulated-epigallocatechin-3-gallate-egcg-modulate-peer-reviewed-article-IJN

Similar Items